SMTL ID : 4fz7.1

Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6-ethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x 0VH: 6-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(6-ethylpyridin-2-yl)amino]pyridazine-3-carboxamide(Non-covalent)

0VH.1: 18 residues within 4Å: Chain A: L.25, G.26, F.30, A.48, K.50, V.81, M.96, E.97, M.98, A.99, G.102, P.103, K.106, R.146, N.147, L.149, S.159, D.160 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.25, A:F.30, A:P.103, A:L.149 Hydrogen bonds: A:E.97, A:A.99, A:R.146, A:S.159, A:D.160 Water bridges: A:N.147, A:D.160, A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lucas, M.C. et al., Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitors. J. Med. Chem. (2014)

Release Date

2013-07-10

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence